Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWoodbois Regulatory News (WBI)

  • This share is currently suspended. It was suspended at a price of 0.03
  • There is currently no data for WBI

Align Research update note

12 Oct 2017 07:00

RNS Number : 3758T
Obtala Limited
11 October 2017
 

Obtala Limited - Conviction Buy. Target price 38.18p

Step change in revenues evident following interims & Q3 update

Obtala Limited is an Africa focussed forestry and agriculture company with a goal of becoming one of Sub-Saharan Africa's largest sustainable food and timber producers.

Interims show period of investment & Woodbois value made apparent

Obtala posted an operating loss of $3.8 million for the six months to 30th June 2017 but a statutory profit of $22.7 million following a gain on the acquisition of Woodbois. An independent valuation of the forestry and timber trading firm added $53.3 million to Obtala's biological asset value. This compares to a revised purchase price for Woodbois of $12.2 million.

Q3 update shows further progress and additional funds raised

The three months to September 2017 saw the end of the forestry close cutting season in Mozambique, the first significant harvests from the agriculture division and the first contribution from the Woodbois acquisition. An additional $2 million has also been raised to support growth via a further preference share in the forestry subsidiary Argento Limited.

Corporate structure re-organised with new Boards appointed

Obtala will now report to the markets via the three divisions of Timber Trading, Timber Production (together the Forestry division) and Agriculture Production. To support this, new boards have been appointed to the Argento (forestry) and Montara (agriculture) subsidiaries.

DCF derived target price of 38.18p suggests 117% upside

Obtala is now seeing a step change in revenue and profit growth across the three divisions of the business. Nevertheless, the shares trade at a substantial discount to net assets, with the market cap c.90% covered by Obtala's stake in Argento alone. Our DCF analysis suggests a target price of 38.18p, therefore we retain our stance of Conviction Buy.

To download the full note visit http://www.alignresearch.co.uk/cpt-company/obtala/

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAMBBPTMBBBBBR
Date   Source Headline
18th Jun 20217:00 amRNSPublication of Sustainability Report
26th May 20217:00 amRNSNotice of AGM and Investor Presentation
18th May 20213:21 pmRNSHolding(s) in Company
17th May 20218:02 amRNSAdmission of Shares
12th May 20219:05 amRNSSecond Price Monitoring Extn
12th May 20219:00 amRNSPrice Monitoring Extension
12th May 20217:00 amRNSResult of Upsized Fundraise
11th May 20214:41 pmRNSPrimaryBid Offer
11th May 20214:39 pmRNSProposed Fundraise up to £5 million
29th Apr 20213:35 pmRNSAcquisition of Veneer Equipment and Offtake
29th Apr 20217:00 amRNSAudited results for FY 2020
7th Apr 20217:00 amRNSQ1 2021 Update
1st Apr 20216:20 pmRNSHolding(s) in Company
24th Mar 20215:45 pmRNSHolding(s) in Company
23rd Mar 20218:30 amRNSConversion of Non-Voting Shares
23rd Mar 20218:25 amRNSHolding(s) in Company
17th Mar 20217:00 amRNSConversion of Non-Voting Shares
16th Mar 20216:17 pmRNSHolding(s) in Company
8th Mar 20217:00 amRNSNew reforestation and carbon credit division
4th Mar 20217:00 amRNSHolding(s) in Company
3rd Mar 20214:15 pmRNSHolding(s) in Company
2nd Mar 20212:30 pmRNSHolding(s) in Company
26th Feb 20217:00 amRNSConversion of 101 million Non-Voting Shares
25th Feb 20216:14 pmRNSHolding(s) in Company
25th Feb 20211:33 pmRNSHolding(s) in Company
25th Feb 20211:32 pmRNSHolding(s) in Company
25th Feb 202111:00 amRNSHolding(s) in Company
18th Feb 20217:03 amRNSConversion of 100 million Non-Voting Shares
18th Feb 20217:00 amRNSHolding(s) in Company
2nd Feb 20214:41 pmRNSSecond Price Monitoring Extn
2nd Feb 20214:36 pmRNSPrice Monitoring Extension
2nd Feb 20212:05 pmRNSSecond Price Monitoring Extn
2nd Feb 20212:00 pmRNSPrice Monitoring Extension
28th Jan 20217:00 amRNSCompany Update
12th Jan 20217:00 amRNSQ4 2020 Update
2nd Dec 20204:41 pmRNSSecond Price Monitoring Extn
2nd Dec 20204:36 pmRNSPrice Monitoring Extension
2nd Dec 20207:00 amRNSOperational Update & Investor Presentation
19th Nov 20202:05 pmRNSSecond Price Monitoring Extn
19th Nov 20202:00 pmRNSPrice Monitoring Extension
5th Nov 20207:00 amRNSIssue of Share Options
8th Oct 20207:00 amRNSQuarterly Update
10th Sep 20201:15 pmRNSDirector/PDMR Shareholding
9th Sep 20208:06 amRNSHolding(s) in Company
8th Sep 20207:00 amRNSHolding(s) in Company
7th Sep 20205:20 pmRNSHolding(s) in Company
7th Sep 20201:30 pmRNSHolding(s) in Company
4th Sep 20205:49 pmRNSHolding(s) in Company
4th Sep 20207:00 amRNSHolding(s) in Company
2nd Sep 20207:00 amRNSHalf Year Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.